Eligible patients received chloroquine ( days 1-3 ) and were randomly assigned ( 1:1:1:1:1:1 ) by a computer-generated randomisation schedule to receive single-dose tafenoquine 50 mg , 100 mg , 300 mg , or 600 mg , primaquine 15 mg for 14 days , or chloroquine alone .